Louisiana State Employees Retirement System Buys New Position in Acadia Healthcare Company, Inc. $ACHC

Louisiana State Employees Retirement System purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 40,900 shares of the company’s stock, valued at approximately $957,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACHC. EverSource Wealth Advisors LLC raised its stake in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares in the last quarter. Wells Fargo & Company MN boosted its position in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares in the last quarter. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare in the 4th quarter worth approximately $52,000. GAMMA Investing LLC lifted its stake in Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its position in shares of Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after acquiring an additional 5,203 shares during the last quarter.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $31.91 on Monday. The firm has a market capitalization of $2.93 billion, a PE ratio of -2.61, a PEG ratio of 10.64 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $32.82. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm’s fifty day simple moving average is $25.70 and its 200 day simple moving average is $21.29.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The firm had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. Cantor Fitzgerald lifted their target price on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. Guggenheim increased their price target on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a report on Monday, May 4th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Finally, TD Cowen raised their target price on shares of Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $26.85.

Get Our Latest Research Report on Acadia Healthcare

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Further Reading

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.